Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SSGJ-705 and SSGJ-612 with or without Chemotherapy in Advanced HER2-Expressing Solid Tumors
NCT07646626Phase 2Recruiting
- Sponsor
- 3SBio
- Start
- Jul 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of SSGJ-705, SSGJ-612 in solid tumor, sponsored by 3SBio. Started Jul 2026; status: recruiting.
02
Drugs
SSGJ-705SSGJ-612
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07646626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07646626.